Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: A retrospective study

Pediatrics

Volumn 117, Issue 6, 2006, Pages 2132-2137

  Berhe, Tseghai ^a,b   Postellon, Daniel ^b   Wilson, Bruce ^b   Stone, Roberta ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Hemoglobin A1c; Hypoglycemia; Insulin pump; Type 1 diabetes

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN LISPRO;

ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPOHYPERTROPHY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; INSULIN INFUSION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SAFETY;

CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEASIBILITY STUDIES; FEMALE; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; RETROSPECTIVE STUDIES; SAFETY;

EID: 33745298028     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2363     Document Type: Article

References (42)

1. Karvenon M, Pitkaniemi J, Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger: the Finnish Childhood Diabetes Registry Group. Diabetes Care. 1999;22:1066-1070
2. Green A, Patterson CC. Trends in the incidence of childhood-onset diabetes in Europe 1989-1999. Diabetologia. 2001;44(suppl 3):B3-B8
3. Onkamo P, Vaananen S, Karvonen M, Tuomilohto J. Worldwide increase in incidence of type I diabetes: the analysis of the data on published incidence trends [published correction appears in Diabetologia. 2000;43:685]. Diabetologia. 1999;42:1395-1403
4. Lumey LH. Variation and trends in the incidence of childhood diabetes in Europe: EURODIAB ACE Study Group. Lancet. 2000;355:873-876
5. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004;328:750-754
6. Hatton DL, Canam C, Thorne S, Hughes AM. Parents' perception of caring for an infant or toddler with diabetes. J Adv Nurs. 1995;22:569-577
7. de Beaufort C. Hypoglycemia during intensified insulin therapy of young children. J Pediatr Endocrinol Metab. 1998;11(suppl 1):153-158
8. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care. 2005;28:15-19
9. Silverstein J, Malone IJ. Strict glycemic control is necessary but not practical in most children with type 1 diabetes. J Clin Endocrinol Metab. 2000;85:2518-2522
10. Rovet J, Ehrlich RM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J Pediatr. 1999;134:503-506
11. Becker D, Ryan CM. Hypoglycemia: a complication of diabetes therapy in children. Trends Endocrinol Metab. 2000;11:198-202
12. Ryan CM, Becker DJ. Hypoglycemia in children with type 1 diabetes mellitus: risk factors, cognitive function, and management. Endocrinol Metab Clin North Am. 1999;28:883-900
13. Schoenle EJ, Shoenle D, Molinari L, Largo RH. Improved intellectual development in children with type 1 diabetes: association with HbA1c, age at diagnosis and sex. Diabetologia. 2002;45:108-114
14. Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long term complications on insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977-985
15. Donaghue KC, Fung ATW, Hing S, et al. The effect of prepubertal diabetes duration on diabetes: microvascular complications in early and late adolescence. Diabetes Care. 1997;20:77-80
16. Scholtz HE, Van Niekerk N, Meyer BH, et al. An assessment of the variability on the pharmacodynamics (glucose lowering effect) of HOE901 compared to NPH and Ultralente human insulins using euglycemic clump technique [abstract 882]. Diabetologia. 1999;42(suppl 1):882
17. Binder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care. 1984;7:188-199
18. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002;141:490-495
19. Bode WB, Tamborlane VW, Davidson PC. Insulin pump therapy in the 21st century: strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med. 2002;111:69-77; quiz 27
20. Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report [published correction appears in Pediatrics. 2005;115:518]. Pediatrics. 2004;114:1601-1605
21. Shehedeh N, Battelino T, Galatzer A, Naveh T, Hadash A, Vries L, Pillip M. Insulin pump therapy for 1-6 year old children with type 1 diabetes. Isr Med Assoc J. 2004;6:284-286
22. Maniatis AK, Klingenmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107:351-356
23. American Diabetes Association; American Dietetic Association. The First Step in Diabetes Meal Planning. Alexandria, VA: American Diabetes Association; 1995
24. Alemzadeh R, Berhe T, Wyatt D. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics. 2005;115:1320-1324
25. Davidson P, Hebblewhite H, Steed R, Bode B. A deductive framework to aid in understanding CSII parameters: carbohydrate-to-insulin ratio (CIR) and correction factor (CF) [abstract 443-P]. Presented at: 63rd Scientific Sessions of the American Diabetes Association; June 13-17, 2003; New Orleans, LA
26. Wessberger-Benchell J, Anistisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care. 2003;26:1079-1087
27. Alemzadeh R, Palma-Sisto P, Parton E, Totka J, Kirby M. Beneficial effect of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. Acta Diabetol. 2003;40:137-142
28. Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes Metab Res Rev. 1999;15:338
29. Kaufman FR, Halvorson M, Fisher L, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients. J Pediatr Endocrinol Metab. 1999;12(suppl 3):759-764
30. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991;90:450-454
31. Ryan V, Vega A, Drash A. Cognitive deficit in adolescents who develop diabetes early in life. Pediatrics. 1985;75:921-927
32. The DCCT Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:1415-1427
33. Blackett PR. Insulin pump treatment for recurrent ketoacidosis in adolescents. Diabetes Care. 1995;18:881-882
34. Tubiana-Rufi N, De Lonlay p, Bloch J, Czernichow P. Remission of severe hypoglycemic incidents in young diabetes children treated with subcutaneous infusion [in French]. Arch Pediatr. 1996;3:969-976
35. Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care. 2004;27:1554-1558
36. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22:1779-1784
37. The DCCT Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trail. Diabetes Care. 1998;11:567-573
38. Libman IM, Pietropaolo M, Arselanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care. 2003;26:2871-2875
39. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002;25:593-598
40. Graff MR, Rubin RR, Walker EA. How diabetes specialists treat their own diabetes: findings from a study of the AADE and ADA membership. Diabetes Educ. 2000;26:460-467
41. Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003;327:383-384
42. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care. 2004;27:955-962